The global veterinary stereotactic radiosurgery system market size is anticipated to reach USD 5.71 billion by 2030, according to a new report published by Grand View Research, Inc. It is expected to expand a CAGR of 10.4% from 2024 to 2030. Rising prevalence of cancer in pets coupled with rising pet ownership and pet owners’ willingness to spend on pet health is expected to drive the market.
According to the Animal Cancer Foundation in 2018, approximately 85% to 98% of primary bone tumors in dogs are osteosarcoma, which is similar to childhood and adolescent osteosarcoma in humans. This disease requires urgent and effective treatment like Stereotactic Radiosurgery (SRS). High prevalence of such diseases is anticipated to drive the growth of the market. Technological advancements in veterinary stereotactic radiosurgery systems coupled with their advantages of Stereotactic Radiotherapy (SRT) over conventional curative radiation therapy are anticipated to further propel the growth. The surgery increases canine survival rate in canines, is further fueling the market growth. For instance, the American College of Veterinary Radiology published a study titled, Safety and Feasibility of Stereotactic Radiotherapy Using Computed Portal Radiography for Canine Intracranial Tumors in 2017. The study concluded that dogs with neurological diseases treated with SRT had a median survival time of 361 days.
The players operating in the veterinary stereotactic radiosurgery system market are collaborating with veterinary professionals and hospitals, in an attempt to increase awareness pertaining to stereotactic radiosurgery system. For instance, in September 2017, SAGE veterinary specialty and emergency animal hospital in Campbell, partnered with PetCure Oncology. The hospital used Halcyon machine, engineered by Varian Medical Systems and also delivered the first SRT treatment to dogs.
According to the Animal Cancer Foundation in 2018, approximately 85% to 98% of primary bone tumors in dogs are osteosarcoma, which is similar to childhood and adolescent osteosarcoma in humans. This disease requires urgent and effective treatment like Stereotactic Radiosurgery (SRS). High prevalence of such diseases is anticipated to drive the growth of the market. Technological advancements in veterinary stereotactic radiosurgery systems coupled with their advantages of Stereotactic Radiotherapy (SRT) over conventional curative radiation therapy are anticipated to further propel the growth. The surgery increases canine survival rate in canines, is further fueling the market growth. For instance, the American College of Veterinary Radiology published a study titled, Safety and Feasibility of Stereotactic Radiotherapy Using Computed Portal Radiography for Canine Intracranial Tumors in 2017. The study concluded that dogs with neurological diseases treated with SRT had a median survival time of 361 days.
The players operating in the veterinary stereotactic radiosurgery system market are collaborating with veterinary professionals and hospitals, in an attempt to increase awareness pertaining to stereotactic radiosurgery system. For instance, in September 2017, SAGE veterinary specialty and emergency animal hospital in Campbell, partnered with PetCure Oncology. The hospital used Halcyon machine, engineered by Varian Medical Systems and also delivered the first SRT treatment to dogs.
Veterinary Stereotactic Radiosurgery System Market Report Highlights
- Particle Beam Radiation Therapy (PBRT) accounted for the largest market share in terms of revenue in 2023, owing to increasing adoption of the product in for neuroscience research in animals
- The LINAC (linear accelerator) systems segment dominated the market and accounted for a share of 53.6% in 2023
- North America held the dominant market share in 2023, due to the factors, such as favorable government policies, new product launches, and rising investment in pet cancer diagnostics
- Latin America is anticipated to witness lucrative growth due to rising pet population, adoption of companion animals coupled with urgent need for effective cancer treatment for pets
The leading players in the Veterinary Stereotactic Radiosurgery System market include:
- Elekta
- Accuracy Incorporated
- Varian Medical Systems, Inc.
- ALCEN
- Xstrahl
Why should you buy this report?
- Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players worldwide.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the global market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segment and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listing for you to stay ahead of the curve
- COVID-19's impact and how to sustain in these fast-evolving markets
Table of Contents
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. Veterinary Stereotactic Radiosurgery System Market Variables, Trends, & Scope
Chapter 4. Veterinary Stereotactic Radiosurgery System Market: Product Estimates & Trend Analysis
Chapter 5. Veterinary Stereotactic Radiosurgery Market: End Use Estimates & Trend Analysis
Chapter 6. Veterinary Stereotactic Radiosurgery System Market: Regional Estimates & Trend Analysis
Chapter 7. Competitive Landscape
Companies Mentioned
The leading players in the Veterinary Stereotactic Radiosurgery System market include:- Elekta
- Accuracy Incorporated
- Varian Medical Systems, Inc.
- ALCEN
- Xstrahl
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 100 |
| Published | September 2024 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value ( USD | $ 2.88 Billion |
| Forecasted Market Value ( USD | $ 5.71 Billion |
| Compound Annual Growth Rate | 10.4% |
| Regions Covered | Global |
| No. of Companies Mentioned | 6 |
